Targets miRBase

  1. Dashboard
  2. Targets

hsa-miR-210-3p (MIMAT0000267) (107 targets) in miRTarBase

miRNA gene name experiments
hsa-miR-210-3p HOXA9
Luciferase reporter assay [1]
hsa-miR-210-3p TP53I11
Luciferase reporter assay [1]
hsa-miR-210-3p PIM1
Luciferase reporter assay [1]
hsa-miR-210-3p HOXA1
Luciferase reporter assay [1]
hsa-miR-210-3p FGFRL1
qRT-PCR [2]
microarray [2]
Western blot [2]
HITS-CLIP [3]
Luciferase reporter assay [1] [2]
hsa-miR-210-3p RAD52
qRT-PCR [4] [5]
Western blot [4]
Luciferase reporter assay [4]
immunoprecipitaion [5]
hsa-miR-210-3p NPTX1
qRT-PCR [5]
Luciferase reporter assay [6]
immunoprecipitaion [5]
hsa-miR-210-3p EFNA3
qRT-PCR [7] [5]
Reporter assay [8]
Western blot [8] [9] [10] [7]
Other [8]
HITS-CLIP [3]
Luciferase reporter assay [6] [8] [9] [10]
immunoprecipitaion [5]
hsa-miR-210-3p BDNF
qRT-PCR [5]
microarray [5]
Western blot [5]
Luciferase reporter assay [5]
Mass spectrometry [5]
immunoprecipitaion [5]
2DGE [5]
hsa-miR-210-3p PTPN1
qRT-PCR [5]
microarray [5]
Western blot [5]
Luciferase reporter assay [5]
Mass spectrometry [5]
immunoprecipitaion [5]
2DGE [5]
hsa-miR-210-3p P4HB
qRT-PCR [5]
microarray [5]
Western blot [5]
Mass spectrometry [5]
immunoprecipitaion [5]
2DGE [5]
hsa-miR-210-3p UBQLN1
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p SERTAD2
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p SEH1L
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p NCAM1
qRT-PCR [5]
microarray [5]
Luciferase reporter assay [5]
immunoprecipitaion [5]
hsa-miR-210-3p MID1IP1
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p MDGA1
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p KIAA1161
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p ISCU
qRT-PCR [5] [11] [12]
microarray [5]
Western blot [11] [13]
HITS-CLIP [3]
Luciferase reporter assay [11] [13]
CLASH [14]
immunoprecipitaion [5]
hsa-miR-210-3p HOXA3
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p GPD1L
qRT-PCR [5]
microarray [5]
Luciferase reporter assay [5]
immunoprecipitaion [5]
hsa-miR-210-3p DENND6A
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p CPEB2
qRT-PCR [5]
microarray [5]
Luciferase reporter assay [5]
immunoprecipitaion [5]
hsa-miR-210-3p CDK10
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p ABCB9
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p CBX1
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p XIST
qRT-PCR [5]
microarray [5]
Luciferase reporter assay [5]
immunoprecipitaion [5]
hsa-miR-210-3p TNPO1
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p SMCHD1
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p PTAR1
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p NIPBL
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p MIB1
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p HECTD1
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p ELK3
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p DDAH1
qRT-PCR [5]
microarray [5]
Luciferase reporter assay [5]
immunoprecipitaion [5]
hsa-miR-210-3p CLASP2
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p CHD9
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p ATP11C
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p APC
qRT-PCR [5]
microarray [5]
immunoprecipitaion [5]
hsa-miR-210-3p E2F3
qRT-PCR [5] [15]
microarray [15]
Western blot [16] [15]
Luciferase reporter assay [16] [17] [15]
immunoprecipitaion [5]
hsa-miR-210-3p ACVR1B
qRT-PCR [5]
immunoprecipitaion [5]
hsa-miR-210-3p MNT
qRT-PCR [7] [18]
Western blot [7] [18]
Luciferase reporter assay [18]
hsa-miR-210-3p AIFM3
qRT-PCR [7]
Western blot [7]
Luciferase reporter assay [19]
hsa-miR-210-3p CASP8AP2
Luciferase reporter assay [20]
hsa-miR-210-3p VMP1
microarray [21]
Western blot [21] [22]
Luciferase reporter assay [22] [21]
hsa-miR-210-3p TFRC
qRT-PCR [23]
HITS-CLIP [3]
Immunoblot [23]
Luciferase reporter assay [23]
Immunohistochemistry [23]
hsa-miR-210-3p PFDN2
CLASH [14]
hsa-miR-210-3p U2AF2
CLASH [14]
hsa-miR-210-3p UBA1
CLASH [14]
hsa-miR-210-3p ESPL1
CLASH [14]
hsa-miR-210-3p ACTR1A
CLASH [14]
hsa-miR-210-3p SCN1B
CLASH [14]
hsa-miR-210-3p RCC2
CLASH [14]
hsa-miR-210-3p HSD17B1
qRT-PCR [24]
Luciferase reporter assay [24]
hsa-miR-210-3p NDUFA4
qRT-PCR [15]
microarray [15]
Western blot [15]
Luciferase reporter assay [25] [15]
hsa-miR-210-3p SDHD
qRT-PCR [15]
microarray [15]
Western blot [15]
Luciferase reporter assay [15] [25]
PAR-CLIP [26]
hsa-miR-210-3p STMN1
qRT-PCR [27]
microarray [27]
In situ hybridization [27]
Immunofluorescence [27]
Luciferase reporter assay [27]
hsa-miR-210-3p DIMT1
qRT-PCR [27]
microarray [27]
In situ hybridization [27]
Immunofluorescence [27]
HITS-CLIP [3]
Luciferase reporter assay [27]
hsa-miR-210-3p PTBP3
qRT-PCR [28]
microarray [28]
Western blot [28]
hsa-miR-210-3p ALDH5A1
qRT-PCR [15]
microarray [15]
Western blot [15]
Luciferase reporter assay [15]
hsa-miR-210-3p FOXN3
qRT-PCR [15]
microarray [15]
Western blot [15]
Luciferase reporter assay [15]
hsa-miR-210-3p MCM3
qRT-PCR [15]
microarray [15]
Western blot [15]
Luciferase reporter assay [15]
hsa-miR-210-3p IGFBP3
qRT-PCR [15]
microarray [15]
Western blot [15]
Luciferase reporter assay [15]
hsa-miR-210-3p COL4A2
qRT-PCR [15]
microarray [15]
Western blot [15]
Luciferase reporter assay [15]
hsa-miR-210-3p INPP5A
qRT-PCR [15]
microarray [15]
Western blot [15]
Luciferase reporter assay [15]
hsa-miR-210-3p EHD2
qRT-PCR [15]
microarray [15]
Western blot [15]
Luciferase reporter assay [15]
hsa-miR-210-3p SH3BGRL
qRT-PCR [15]
microarray [15]
Western blot [15]
HITS-CLIP [3]
Luciferase reporter assay [15]
hsa-miR-210-3p PTPN2
qRT-PCR [29]
ChIP [29]
Western blot [29]
Luciferase reporter assay [29]
hsa-miR-210-3p LDHA
qRT-PCR [30]
Luciferase reporter assay [30]
hsa-miR-210-3p LDHB
qRT-PCR [30]
Luciferase reporter assay [30]
hsa-miR-210-3p HIF1A
qRT-PCR [7]
Western blot [7]
hsa-miR-210-3p FOXP3
qRT-PCR [31]
Western blot [31]
Luciferase reporter assay [31]
hsa-miR-210-3p HIF3A
qRT-PCR [32]
Western blot [32]
Luciferase reporter assay [32]
hsa-miR-210-3p MGRN1
HITS-CLIP [3]
PAR-CLIP [26]
hsa-miR-210-3p INSIG1
HITS-CLIP [3]
hsa-miR-210-3p BNIP3
qRT-PCR [33]
Western blot [33]
Luciferase reporter assay [33]
hsa-miR-210-3p KCMF1
Luciferase reporter assay [34]
hsa-miR-210-3p TNPO3
HITS-CLIP [3]
hsa-miR-210-3p SIPA1L3
HITS-CLIP [3]
hsa-miR-210-3p SIN3A
HITS-CLIP [3]
hsa-miR-210-3p RPL22
HITS-CLIP [3]
hsa-miR-210-3p PSAP
HITS-CLIP [3]
hsa-miR-210-3p PPP1R2
HITS-CLIP [3]
hsa-miR-210-3p POU2AF1
HITS-CLIP [3]
hsa-miR-210-3p ICMT
HITS-CLIP [3]
PAR-CLIP [26]
hsa-miR-210-3p MEF2D
HITS-CLIP [3]
hsa-miR-210-3p HMGCS1
HITS-CLIP [3]
PAR-CLIP [26]
hsa-miR-210-3p GIT2
HITS-CLIP [3]
hsa-miR-210-3p FCHSD2
HITS-CLIP [3]
hsa-miR-210-3p DEAF1
HITS-CLIP [3]
hsa-miR-210-3p CSNK1E
HITS-CLIP [3]
hsa-miR-210-3p NFIC
PAR-CLIP [26]
hsa-miR-210-3p MITF
PAR-CLIP [26]
hsa-miR-210-3p DYRK2
PAR-CLIP [26]
hsa-miR-210-3p ZNF607
PAR-CLIP [35]
hsa-miR-210-3p SERTM1
HITS-CLIP [36]
PAR-CLIP [37] [38] [36]
hsa-miR-210-3p CNTNAP5
HITS-CLIP [36]
PAR-CLIP [37] [36]
hsa-miR-210-3p PKIA
PAR-CLIP [38] [39]
hsa-miR-210-3p RUNX1T1
HITS-CLIP [36] [40]
PAR-CLIP [36]
hsa-miR-210-3p ESCO2
PAR-CLIP [36]
hsa-miR-210-3p KCNJ6
PAR-CLIP [38]
hsa-miR-210-3p DOCK7
HITS-CLIP [36]
PAR-CLIP [38]
hsa-miR-210-3p VAMP4
HITS-CLIP [41]
hsa-miR-210-3p TNRC6B
HITS-CLIP [42] [43]
hsa-miR-210-3p SLCO3A1
HITS-CLIP [40]
hsa-miR-210-3p GTDC1
HITS-CLIP [40]
hsa-miR-210-3p ASB11
HITS-CLIP [42]

References

authors journal year Pubmed link title
1 Huang et al. Mol. Cell 2009 19782034 Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation.
2 Tsuchiya et al. J. Biol. Chem. 2011 21044961 MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1).
3 Riley et al. EMBO J. 2012 22473208 EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency.
4 Crosby et al. Cancer Res. 2009 19141645 MicroRNA regulation of DNA repair gene expression in hypoxic stress.
5 Fasanaro et al. J. Biol. Chem. 2009 19826008 An integrated approach for experimental target identification of hypoxia-induced miR-210.
6 Pulkkinen et al. FEBS Lett. 2008 18539147 Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210.
7 Yang et al. Radiat Oncol 2013 23618526 Effects of knockdown of miR-210 in combination with ionizing radiation on human hepatoma xenograft in nude mice.
8 Fasanaro et al. J. Biol. Chem. 2008 18417479 MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3.
9 Greither et al. Int. J. Cancer 2010 19551852 Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival.
10 Xiao et al. Glycobiology 2013 23322395 WSS25 inhibits Dicer, downregulating microRNA-210, which targets Ephrin-A3, to suppress human microvascular endothelial cell (HMEC-1) tube formation.
11 Chan et al. Cell Metab. 2009 19808020 MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2.
12 Muralimanoharan et al. Placenta 2012 22840297 MIR-210 modulates mitochondrial respiration in placenta with preeclampsia.
13 Lee et al. Am. J. Pathol. 2011 21801864 miR-210 targets iron-sulfur cluster scaffold homologue in human trophoblast cell lines: siderosis of interstitial trophoblasts as a novel pathology of preterm preeclampsia and small-for-gestational-age pregnancies.
14 Helwak et al. Cell 2013 23622248 Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding.
15 Bertero et al. PLoS ONE 2012 23028679 "Seed-Milarity" confers to hsa-miR-210 and hsa-miR-147b similar functional activity.
16 Giannakakis et al. Cancer Biol. Ther. 2008 18059191 miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer.
17 Nakada et al. J. Pathol. 2011 21465485 Overexpression of miR-210, a downstream target of HIF1α, causes centrosome amplification in renal carcinoma cells.
18 Zhang et al. Cell Cycle 2009 19652553 MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT.
19 Yang et al. Exp. Cell Res. 2012 22387901 Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro.
20 Kim et al. J. Biol. Chem. 2009 19721136 Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2.
21 Ying et al. Hepatology 2011 22144109 Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma.
22 Qu et al. PLoS ONE 2014 24632577 Hypoxia-inducible MiR-210 is an independent prognostic factor and contributes to metastasis in colorectal cancer.
23 Yoshioka et al. J. Biol. Chem. 2012 22896707 Micromanaging Iron Homeostasis: hypoxia-inducible micro-RNA-210 suppresses iron homeostasis-related proteins.
24 Ishibashi et al. Hypertension 2012 22203747 Hydroxysteroid (17-β) dehydrogenase 1 is dysregulated by miR-210 and miR-518c that are aberrantly expressed in preeclamptic placentas: a novel marker for predicting preeclampsia.
25 Grosso et al. Cell Death Dis 2013 23492775 MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines.
26 Whisnant et al. MBio 2013 23592263 In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms.
27 Kiga et al. Nat Commun 2014 25187177 Epigenetic silencing of miR-210 increases the proliferation of gastric epithelium during chronic Helicobacter pylori infection.
28 Fasanaro et al. PLoS ONE 2012 23024754 ROD1 is a seedless target gene of hypoxia-induced miR-210.
29 Kim et al. Cell Death Dis 2013 23579275 Reactive oxygen species-responsive miR-210 regulates proliferation and migration of adipose-derived stem cells via PTPN2.
30 Saumet et al. Mol Biosyst 2012 23064179 Estrogen and retinoic acid antagonistically regulate several microRNA genes to control aerobic glycolysis in breast cancer cells.
31 Zhao et al. Clin. Immunol. 2014 24316592 Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4(+) T cells of psoriasis vulgaris.
32 Gits et al. BMC Cancer 2014 24927770 MicroRNA response to hypoxic stress in soft tissue sarcoma cells: microRNA mediated regulation of HIF3α.
33 Wang et al. Stem Cell Res 2013 23688833 miR-210 suppresses BNIP3 to protect against the apoptosis of neural progenitor cells.
34 Luo et al. Hypertension 2014 24980667 MicroRNA-210 contributes to preeclampsia by downregulating potassium channel modulatory factor 1.
35 Skalsky et al. PLoS Pathog. 2012 22291592 The viral and cellular microRNA targetome in lymphoblastoid cell lines.
36 Kishore et al. Nat. Methods 2011 21572407 A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins.
37 Memczak et al. Nature 2013 23446348 Circular RNAs are a large class of animal RNAs with regulatory potency.
38 Hafner et al. Cell 2010 20371350 Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP.
39 Lipchina et al. Genes Dev. 2011 22012620 Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response.
40 Xue et al. Cell 2013 23313552 Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits.
41 Pillai et al. Breast Cancer Res. Treat. 2014 24906430 HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancer.
42 Chi et al. Nature 2009 19536157 Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps.
43 Karginov et al. Genes Dev. 2013 23824327 Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates.
Imprint Data protection